This may be attributed to the younger age of diagnosis as well as the higher proportion of pre-menopausal patients in WSI compared to TCGA as the proportion of patients who are carrier of breast cancer predisposition genes, such as BRCA1 and BRCA2, are anticipated to be higher in younger populations of breast cancer patients [22, 23]. The gene discussed is BRCA1; the disease is breast cancer.